Key result
Comprehensive clinical and pathological analysis proves essential for accurately differentiating rare vascular tumors.
Why the study?
The histological boundary between benign and malignant vascular tumors is unclear, leading to discrepancies between clinical judgement and pathological diagnosis that complicate clinical decisions and may cause misdiagnosis.
Case Report (n=3)
No
Highlights the importance of comprehensive clinical and pathological analysis in diagnosing and managing rare vascular tumors to avoid misdiagnosis.
Case-based evidence supports thorough workup for rare vascular tumors; leaves open need for validation in larger cohorts.
The histological boundary between benign and malignant vascular tumors is not clear. Thus, the discrepancies between clinical judgement and pathological diagnosis often lead to a difficult clinical decision, and may result in misdiagnosis. In order to develop more effective treatment methods, the clinical and pathological data concerning rare vascular tumors should be comprehensively analyzed. To clarify the important roles of clinical and pathological analyses in vascular tumors, three rare vascular tumor cases that we encountered in clinical practice are analyzed and reported in detail.
No takes yet. Share an insight, caveat, or question.
Li et al. (2012) conducted a case report in Rare vascular tumors (n=3). Clinical and pathological analysis was evaluated on Pathological and clinical characteristics. Comprehensive clinical and pathological analysis, including immunohistochemical staining, is essential for the accurate diagnosis and differentiation of rare benign and malignant vascular tumors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: